VIMU
MDT icon

Veritas Investment Management (UK)’s Medtronic MDT Stock Holding History

Veritas Investment Management (UK)’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,761
Closed -$182K – 24
2021
Q4 		$182K Hold
1,761
– – 0.03% 30
2021
Q3 		$221K Hold
1,761
– – 0.04% 35
2021
Q2 		$219K Buy
+1,761
New +$221K 0.04% 38

Other funds holding MDT

WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Veritas Investment Management (UK)'s MDT Position: Q1 2022 in Review

Veritas Investment Management (UK) sold out of Medtronic (MDT) in Q1 2022, closing a stake of 1,761 shares — an estimated $182K sold.

Veritas Investment Management (UK) first reported a position in MDT in Q2 2021 and held it in 3 quarters. The position peaked at $221K in Q3 2021. 2,102 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

  • Veritas Investment Management (UK) reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
  • Veritas Investment Management (UK) sold 1,761 Medtronic shares in Q1 2022, an estimated $182K.
  • Veritas Investment Management (UK) first reported a position in Medtronic in Q2 2021 and held it in 3 quarters.
  • Veritas Investment Management (UK)'s Medtronic position peaked at $221K in Q3 2021.
  • 2,102 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Veritas Investment Management (UK)'s 13F filing for Q1 2022.